Posts By Alex
-
688Wire StoriesArista Unveils Attack Surface Assessment Service
Delivers AI-driven advanced threat hunting and incident response expertise SANTA CLARA, Calif.–(BUSINESS WIRE)–Arista Networks (NYSE:ANET) today announced an Attack Surface Assessment, an...
-
800Wire Stories
HitGen Announces License Agreement With Merck & Co., Inc., Kenilworth, NJ USA to Access Compounds for Potential Development of a Novel Class of Drugs
CHENGDU, China–(BUSINESS WIRE)–HitGen Inc. is pleased to announce that HitGen and Merck & Co., Inc., Kenilworth, NJ USA, known as MSD outside...
-
780Wire Stories
Propanc Biopharma Receives First Granted Patent for Method to Treat Cancer Stem Cells from Australian Patent Office
MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTC: PPCB) (�Propanc� or the �Company�), a biopharmaceutical company developing novel cancer treatments for patients suffering from...
-
662Wire Stories
Middleby Acquires United Foodservice
ELGIN, Ill.–(BUSINESS WIRE)–The Middleby Corporation (NASDAQ: MIDD) today announced the acquisition of Zhuhai Guangdong China-based United Foodservice Equipment Group. The company is...
-
835Wire Stories
First Patients, Including a COVID-19 Patient, Treated with Abiomed�s Innovative ECMO Technology
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (NASDAQ: ABMD) announces the first two patients in the world have been treated with the Abiomed Breethe OXY-1 System,...
-
698Wire Stories
Azura Ophthalmics Announces Primary Endpoints Met in Topline Results from Phase 2 Trial of the Company�s Investigational Treatment for Contact Lens Discomfort
Significant improvement in multiple measures of Meibomian gland secretion and associated improvements in contact lens wear time TEL AVIV, Israel & MELBOURNE,...
-
748Wire Stories
Regenacy Announces the Formation of a Joint Venture with 3E Bioventures to Develop Ricolinostat in China and the Start of a U.S. Phase 2 Study in Painful Diabetic Peripheral Neuropathy
WALTHAM, Mass.–(BUSINESS WIRE)–Regenacy Pharmaceuticals, a clinical-stage biopharmaceutical company developing breakthrough treatments for diabetic and other peripheral neuropathies, and 3E Bioventures Capital, a...
-
689Wire Stories
Legend Biotech Announces Initiation of Rolling Submission of Biologics License Application to U.S. FDA Seeking Approval of BCMA CAR-T Therapy Cilta-cel for the Treatment of Relapsed and/or Refractory Multiple Myeloma
Legend Biotech also achieves fifth milestone payment under its collaboration agreement with Janssen in clinical development of cilta-cel SOMERSET, N.J.–(BUSINESS WIRE)–#LegendBiotech–Legend Biotech...
-
1.0KWire Stories
TAGRISSO Approved in the US for the Adjuvant Treatment of Patients With Early-Stage EGFR-mutated Lung Cancer
Approval based on unprecedented results from the ADAURA Phase III trial where TAGRISSO reduced the risk of disease recurrence or death by...
-
663Wire Stories
Xpeng Delivers G3 Smart Electric SUV to First Customers in Norway, Stepping Up Plans for European Market
Xpeng G3 is a smart EV with a range of 520km NEDC (451km WLTP) Norway represents company�s first step into Europe, with...
